News
Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034
Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034
Biotech investments fuel DNA manufacturing in Asia-Pacific.
Australia grants $450,000 funding boost to fast-track cancer trials
This brings total investments to $975,000.
Australia kicks off first stage of $630m Fairfield Hospital project
This includes plans for a new 460-space multi-storey car park.
Intelligent wound closure fuels surgical stapler market to $10.3b
The Asia-Pacific is emerging as the fastest-growing market.
SGH and Redesign Health to build startups, new tech in 3-year deal
Under the MoU, SGH will provide access to clinicians and research, amongst others.
KPJ Healthcare opens first neuroscience centre at Damansara hospital
It provides 24-hour access to advanced CT and MRI.
Lipid nanoparticles market to reach $3.1b by 2033 as chronic diseases rise
The adoption of mRNA-based vaccines will also fuel demand.
Reproductive health disorders to drive female tech market to $26.1b by 2033
It will expand at a compound annual growth rate of 15.2%.
Nanomedicine market poised for double-digit growth
It is driven by the rising prevalence of chronic diseases.
Burjeel Holdings net profit rises 39.5% YoY to $136.9m
Total revenue also increased by 9.5% YoY to $1.47b.
AI and mobile integration drive surge in smart inhaler adoptions
Rising need for personalised and remote healthcare also drives adoption.
$110m funding boost to support Australians with chronic conditions
Chronic conditions cause 90% of deaths and affect most Australians.
Structural heart devices market to reach $2.93b by 2032
Asia Pacific is the fastest-growing region with a 10.0% CAGR.
Rising CKD cases and advanced biomarkers fuel $4.8b market growth
Market growth is expected to continue through 2034.
Peripheral vascular devices market to reach $15.5b by 2032
Increasing prevalence of PAD and lifestyle-related vascular disorders drives demand.
Global prescription drugs market to reach $2.26t by 2034
The Asia Pacific region is projected to register the fastest growth rate.
Rising cases, advanced diagnostics drive biliary tract cancer market growth across 7MM
Increasing cases were driven by aging populations and liver diseases.
Most Read
1. China healthcare firms offset policy pressure with global growth 2. Private hospital plan takes shape in Singapore amidst public hospital overload 3. Kai Tak Hospital to launch first phase of services in October 4. Lung cancer surgery market set for $2.8b expansion by 2036 on rising cases 5. How can the Philippines fix health funding imbalances?Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Healthcare Asia Awards 2026 Winner: Dr Omid Etemadi, Singapore Cancer Center Inc. by Curie Oncology
Dr Omid Etemadi of Singapore Cancer Center Inc.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight